These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22410542)

  • 41. Tissue-engineered mitral valve: morphology and biomechanics †.
    Iablonskii P; Cebotari S; Tudorache I; Granados M; Morticelli L; Goecke T; Klein N; Korossis S; Hilfiker A; Haverich A
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):712-9; discussion 719. PubMed ID: 25762708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cell-derived, tissue-engineered pulmonary artery augmentation patches in vivo.
    Mettler BA; Sales VL; Stucken CL; Anttila V; Mendelson K; Bischoff J; Mayer JE
    Ann Thorac Surg; 2008 Jul; 86(1):132-40; discussion 140-1. PubMed ID: 18573411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcatheter treatment of tricuspid regurgitation by caval valve implantation--experimental evaluation of decellularized tissue valves in central venous position.
    Lauten A; Laube A; Schubert H; Bischoff S; Nietzsche S; Horstkötter K; Poudel-Bochmann B; Franz M; Lichtenberg A; Figulla HR; Akhyari P
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):150-60. PubMed ID: 24403276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model.
    Bastijanic JM; Marchant RE; Kligman F; Allemang MT; Lakin RO; Kendrick D; Kashyap VS; Kottke-Marchant K
    J Vasc Surg; 2016 Jun; 63(6):1620-1630.e4. PubMed ID: 25827964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is Transcatheter Aortic Valve Implantation of Living Tissue-Engineered Valves Feasible? An In Vitro Evaluation Utilizing a Decellularized and Reseeded Biohybrid Valve.
    Koenig F; Lee JS; Akra B; Hollweck T; Wintermantel E; Hagl C; Thierfelder N
    Artif Organs; 2016 Aug; 40(8):727-37. PubMed ID: 27187768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Historical overview of venous valve prostheses for the treatment of deep venous valve insufficiency.
    Zervides C; Giannoukas AD
    J Endovasc Ther; 2012 Apr; 19(2):281-90. PubMed ID: 22545896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic evaluation of a bioprosthetic venous prosthesis.
    DeLaria GA; Phifer T; Roy J; Tu R; Thyagarajan K; Quijano RC
    J Vasc Surg; 1993 Oct; 18(4):577-84; discussion 584-6. PubMed ID: 8411465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves.
    Stock UA; Degenkolbe I; Attmann T; Schenke-Layland K; Freitag S; Lutter G
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1323-30. PubMed ID: 16733165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue-engineered transcatheter vein valve.
    Syedain ZH; Jenson AC; Patel PS; Feagler C; Bahmer L; Faizer R; Tranquillo RT
    Biomaterials; 2019 Sep; 216():119229. PubMed ID: 31195302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue engineering heart valves: valve leaflet replacement study in a lamb model.
    Shinoka T; Breuer CK; Tanel RE; Zund G; Miura T; Ma PX; Langer R; Vacanti JP; Mayer JE
    Ann Thorac Surg; 1995 Dec; 60(6 Suppl):S513-6. PubMed ID: 8604922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental in vitro endothelialization of cardiac valve leaflets.
    Eberl T; Siedler S; Schumacher B; Zilla P; Schlaudraff K; Fasol R
    Ann Thorac Surg; 1992 Mar; 53(3):487-92. PubMed ID: 1540068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves.
    Sales VL; Mettler BA; Engelmayr GC; Aikawa E; Bischoff J; Martin DP; Exarhopoulos A; Moses MA; Schoen FJ; Sacks MS; Mayer JE
    Tissue Eng Part A; 2010 Jan; 16(1):257-67. PubMed ID: 19698056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft.
    Goldstein S; Clarke DR; Walsh SP; Black KS; O'Brien MF
    Ann Thorac Surg; 2000 Dec; 70(6):1962-9. PubMed ID: 11156103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts.
    Emmert MY; Weber B; Behr L; Sammut S; Frauenfelder T; Wolint P; Scherman J; Bettex D; Grünenfelder J; Falk V; Hoerstrup SP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):61-8. PubMed ID: 23657551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the endothelialization of small intestinal submucosa, dacron, and expanded polytetrafluoroethylene suspended in the thoracoabdominal aorta in sheep.
    Yavuz K; Geyik S; Pavcnik D; Uchida BT; Corless CL; Hartley DE; Goktay A; Correa LO; Timmermans H; Hodde JP; Kaufman JA; Keller FS; Rösch J
    J Vasc Interv Radiol; 2006 May; 17(5):873-82. PubMed ID: 16687754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts.
    Deutsch M; Meinhart J; Zilla P; Howanietz N; Gorlitzer M; Froeschl A; Stuempflen A; Bezuidenhout D; Grabenwoeger M
    J Vasc Surg; 2009 Feb; 49(2):352-62; discussion 362. PubMed ID: 19110397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro evaluation of a new autologous valve-stent for deep venous incompetence.
    Geselschap JH; van Zuiden JM; Toonder IM; Wittens CH
    J Endovasc Ther; 2006 Dec; 13(6):762-9. PubMed ID: 17154702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.